About Thyro-Med 3 Bioniche Pharma (Liothyronine Sodium) 60tabs (
Thyro-Med 3 is a synthetic thyroid hormone preparation containing Liothyronine Sodium (T3) manufactured by Bioniche Pharmaceuticals. Each tablet delivers precisely 25mcg of active compound, making it suitable for controlled laboratory investigations into thyroid hormone metabolism and cellular energy pathways. This research-grade formulation enables scientists at Stroid UK Shop to examine T3’s effects on mitochondrial function, protein synthesis regulation, and metabolic rate modulation in experimental models. The compound represents the active form of thyroid hormone that directly influences cellular metabolism without requiring peripheral conversion from T4.
Laboratory Applications
Researchers investigate Liothyronine Sodium for its profound effects on cellular metabolism and energy expenditure in controlled laboratory settings. Studies examine how T3 regulates mitochondrial biogenesis, uncoupling protein expression, and thermogenic pathways in adipose tissue models. The compound’s rapid onset and short half-life make it valuable for acute metabolic intervention studies. Scientists also explore T3’s interaction with beta-adrenergic signalling pathways and its role in metabolic enhancement research. Additional investigations focus on thyroid hormone’s effects on cardiac metabolism, skeletal muscle protein turnover, and hepatic gluconeogenesis. The precise 25mcg dosing allows for accurate titration in dose-response studies examining metabolic threshold effects.
Compound Specifications
| Parameter | Value |
|---|---|
| Active Compound | Liothyronine Sodium (T3) |
| Strength per Tablet | 25mcg |
| Tablet Count | 60 tablets |
| Molecular Formula | C₁₅H₁₁I₃NNaO₄ |
| Molecular Weight | 672.96 g/mol |
| CAS Number | 55-06-1 |
| Manufacturer | Bioniche Pharmaceuticals |
| Storage Requirements | Room temperature, dry conditions |
The pharmaceutical-grade manufacturing ensures consistent potency and purity for reliable experimental results. Each batch undergoes quality control testing to verify active ingredient content and tablet uniformity. Researchers studying selective modulators often compare T3’s broad metabolic effects with more targeted compounds. The stable sodium salt formulation provides extended shelf-life and predictable bioavailability in research models. Scientists investigating metabolic peptides frequently use T3 as a positive control for thermogenic pathway activation studies.
Research Compliance
Thyro-Med 3 Liothyronine Sodium is manufactured exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. All studies must comply with institutional research protocols and applicable regulations governing laboratory use of research chemicals. Researchers should consult relevant safety data sheets and follow appropriate handling procedures when conducting studies with this compound.
